Do you want to read an article? Please log in or register.
Lorlatinib-associated weight gain and dyslipidaemia: A retrospective analysis and implications for future care
Lung, Respiratory and Thoracic Cancer
Related content
Lung, Respiratory and Thoracic Cancer
Body Weight Gain Associated With Alectinib in Patients With ALK+ Non-Small Cell Lung Cancer: Pooled Analysis of Individual Patient Data From Four Prospective Clinical Trials
J Clin Oncol
Sikkema BJ, Baart SJ, Paats MS, Smit EF, Schols AMWJ, Mathijssen RHJ, van Rossum EFC, Dingemans AC
doi: 10.1200/JCO-24-01579
Radio-Oncology
Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation
Lancet Oncol
Lichter KE, Charbonneau K, Lewy JR, Bloom JR, Shenker R, Sabbagh A, Chino J, Rodrigues A, Hearn J, Grover S, Sheu RD, Witztum A, Qureshi MM, Yom SS, Anand C, Thiel CL, Mohamad O
doi: 10.1016/S1470-2045(24)00148-7
RECOMMENDED
Further Publications
Association of metformin use and cancer incidence: a systematic review and meta-analysis
★ 2
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
J Natl Cancer Inst
O'connor L, Bailey-Whyte M, Bhattacharya M, Buttera G, Hardell KNL, Seidenberg AB, Castle PE, Loomans-Kropp HA
doi: 10.1093/jnci/djae021
Leukemia
Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS
Int J Cancer
Song Z, Wang Y, Zhang D, Wang T, Liu N, Gao L, Wang L, Yang J
doi: 10.1002/ijc.35235
Multiple Myeloma (MM)
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis
Leuk Lymphoma
Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N
doi: 10.1080/10428194.2024.2446617
Lung, Respiratory and Thoracic Cancer
Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC)
Lung Cancer
Ou SH, Kilvert H, Candlish J, Lee B, Polli A, Thomaidou D, Le H
doi: 10.1016/j.lungcan.2024.107968
Genitourinary Cancer
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Cancer Treat Rev
Zhang Y, Chen J, Liu H, Dai J, Zhao J, Zhu S, Zhang X, Liang J, Hu X, Zhao J, Liu Z, Shen P, Sun G, Zeng H
doi: 10.1016/j.ctrv.2024.102787
Further Publications
Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis
Lancet Oncol
Naci H, Zhang Y, Woloshin S, Guan X, Xu Z, Wagner AK
doi: 10.1016/S1470-2045(24)00152-9
Gastrointestinal Cancer
Association of robotic surgery with early discharge, readmission, and complications in elective colectomy: an analysis of NSQIP data from 2012 to 2021
J Robot Surg
Hsu AT, Zion M, Powell J, D'Adamo CR, Feinman M, Felton J, Wolf JH
doi: 10.1007/s11701-024-02121-3